Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 355
  • Home
  • Print this page
  • Email this page

 Table of Contents  
SHORT REPORT
Year : 2021  |  Volume : 8  |  Issue : 6  |  Page : 720-724

Integration of Machine Learning and Blockchain Technology in the Healthcare Field: A Literature Review and Implications for Cancer Care


1 Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Hong Kong, China
2 Department of Nursing, Yunnan Cancer Hospital, Kunming, China
3 Department of Oncology, Affiliated Hospital of Southwest Medical University, Luzhou, China

Date of Submission14-May-2021
Date of Acceptance04-Aug-2021
Date of Web Publication04-Oct-2021

Correspondence Address:
Andy SK Cheng
Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Hong Kong
China
Yingchun Zeng
Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Hong Kong
China
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/apjon.apjon-2140

Rights and Permissions
  Abstract 


This brief report aimed to describe a narrative review about the application of machine learning (ML) methods and Blockchain technology (BCT) in the healthcare field, and to illustrate the integration of these two technologies in cancer survivorship care. A total of six eligible papers were included in the narrative review. ML and BCT are two data-driven technologies, and there is rapidly growing interest in integrating them for clinical data management and analysis in healthcare. The findings of this report indicate that both technologies can integrate feasibly and effectively. In conclusion, this brief report provided the state-of-art evidence about the integration of the most promising technologies of ML and BCT in health field, and gave an example of how to apply these two most disruptive technologies in cancer survivorship care.

Keywords: Artificial intelligence, Blockchain, Cancer care, Machine learning


How to cite this article:
Cheng AS, Guan Q, Su Y, Zhou P, Zeng Y. Integration of Machine Learning and Blockchain Technology in the Healthcare Field: A Literature Review and Implications for Cancer Care. Asia Pac J Oncol Nurs 2021;8:720-4

How to cite this URL:
Cheng AS, Guan Q, Su Y, Zhou P, Zeng Y. Integration of Machine Learning and Blockchain Technology in the Healthcare Field: A Literature Review and Implications for Cancer Care. Asia Pac J Oncol Nurs [serial online] 2021 [cited 2021 Oct 24];8:720-4. Available from: https://www.apjon.org/text.asp?2021/8/6/720/327474




  Introduction Top


Globally, there was an estimated 19.3 million new cancer cases and approximately 10.0 million cancer deaths in 2020.[1] With the advanced development of cancer therapies, the overall 5-year relative survival rate for all cancers increased steadily and was over 50%.[2],[3] In Asia-Pacific region, some countries such as in Australia the latest average 5-year relative survival of cancer patients is as high as 72%.[4] Although new cancer therapies improve the overall survival rate, the burden of cancer is a global phenomenon.[5]

Continuous advancement in technology such as the applications of artificial intelligence (AI) into clinical oncology and research offers potential solutions in reducing the burden of cancer.[5] AI is the term of using computers to model intelligent behavior with minimal human intervention either by physical or virtual approach,[6] and this report applied AI by the virtual approach such as through machine learning (ML). However, a major challenge in cancer management is classifying patients into appropriate risk groups for better treatment and follow-up.[7] To address this major challenge in cancer management, the application of ML may offer the possible solution.

ML is a suitable method for classifying patients into high- or low-risk groups, as ML methods utilize various statistical, probabilistic, and optimization techniques, which train computers to learn and detect patterns from large and complex cancer datasets.[7] For example, some ML methods, including support vector machine, semi-supervised learning, and decision tree, have been applied to cancer prediction and prognosis.[8],[9],[10] Compared with traditional statistical methods for prediction, ML has its own strengths in handling large volumes of multi-omics data with noisy or missing data.[7],[10] Access to a complete history of cancer patients' data is restricted due to high patient mobility across multiple hospitals or clinics,[11] however, using ML techniques for cancer disease status and prognosis prediction can empower personalized medicine and enhance the quality of cancer care.[11],[12]

However, the key barrier of achieving personalized medicine or nursing is isolated data islands owned from different medical institutions. As widely and timely sharing of healthcare data is essential in providing prompt cancer treatment, and monitoring posttreatment effects to optimize the care delivered.[11] Blockchain technology (BCT) has been suggested as a promising tool to store healthcare-related data for sharing, exchanging, and analysis purposes among different providers.[13] The benefits of Blockchain for cancer applications include decentralization, improved data security and privacy, medical data owned by patients, data verifiability, transparency, and trust.[14] Several attempts have applied BCT to generate comprehensive profiles of cancer patients,[11],[15],[16] as BCT is a new type of digital architecture, treated as a distributed ledger to ensure the resilience, traceability, and management of healthcare data.[17]

BCT can also act as a digital backbone for interfacing with other AI technologies, including ML.[15],[17] Thus, BCT is expansive and modular and has the flexibility to be adopted for a variety of applications in cancer care.[17] The advantages of integrating both ML and BCT are increasing data security and transparency, so that clinicians or oncology researchers can better open up isolated data islands based on the BCT's strong data storage capabilities in an encrypted, distributed ledger format, and be informed decisions based on the ML's predictive capabilities.[10],[18] Therefore, this brief report aimed to explore the application of ML and BCT in the healthcare field and to illustrate the integration of these two data-focused innovations in cancer survivorship care.


  Methods Top


This brief report included two stages. Stage one is a narrative review, which conducted literature search among the following databases: PubMed, IEEE Xplore, and Google Scholar. Initially, the search terms consisted of (”machine learning” OR “deep learning”), AND (”block chain” OR “blockchain” OR “distributed ledger”), AND (”health” OR “healthcare”). This review included peer-reviewed journal articles or conference proceedings until the end of February 2021. Stage two is a brief study protocol to illustrate how to apply these two cutting-edge technologies in cancer survivorship care.


  Results Top


For stage one, it included six studies involving the integration of ML methods and BCT. As shown in [Table 1], the main contribution of these selected studies proposes integrating BCT and ML in a sequential order from disease surveillance, disease prevention, and disease treatment to health maintenance. For example, disease surveillance,[19],[20] disease prevention by early prediction of disease or its symptoms,[21],[22] disease treatment such as in the field of drug discovery and development,[15] and health maintenance such as privacy-preserving health care to obtain health patterns.[22],[23] Kuo and Ohno-Machado[22] proposed the ModelChain framework, which utilizes a permissioned Blockchain coupled with an ML model to increase the security of distributed preserving healthcare and accurately gain predictive patterns.
Table 1: Summary of characteristics of included studies

Click here to view


Guided by the ModelChain framework,[22] the second stage of this report illustrated how to integrate ML and BCT into cancer survivorship care [Figure 1]. As the application of BCT can open up isolated data islands among different medical institutions to achieve data sharing of cancer diagnosis and treatment information, then integrating the method of ML to automatically predict the high risk of cancer recurrence or prognosis prediction by extracting different medical databases across different medical institutions to establish a classification index. In combination with locating cancer survivors' environmental data and regional healthcare service, this BCT and ML system can apply a rule-based expert system (the simplest form of AI uses prescribed knowledge-based rules from a human expert and convert this into a number of hardcoded rules to solve a problem),[24] to automatically matching cancer survivors' individual healthcare needs with personalized survivorship care service.
Figure 1: Proposed study framework of integrating machine learning and blockchain technology in cancer survivorship care

Click here to view



  Discussion Top


This report aimed to explore the possibility of integrating the ML and BCT in the healthcare field and to draw implications for cancer care, as the application of BCT in the healthcare field is still in its infancy, and there is scant literature regarding the convergence of ML and BCT in health care. Of the six included papers, only one study mentioned the possible implications for cancer care,[15] but other papers may also have potential implications for cancer care.[19],[20],[21],[22],[23]

As the optimization of cancer care should deeply integrate ML and BCT, the successful integration and implementation of these two promising technologies in cancer care delivery could open new research avenues for the advancement of cancer research.[11],[12],[25] In 2018, a Medicalchain in the United Kingdom was created by using BCT to record patients' medical information.[26] This Medicalchain platform incorporating other AI technologies, including ML, to monitor and analyze cancer risk for moving the cancer prevention and control forward, which significantly improves the capability of cancer prevention and reduces the burden of cancer.[26]

BCT is still in early-stage development and application in cancer care, so regulations and data-sharing standards should be established and updated, based on technology requirements, along with sustainability, technological, and information management perspectives.[27] As BCT is a relatively new technology, there is also a need to evaluate the long-term issues associated with this technology.[28] Further, we still need to develop an understanding of BCT and its integration with ML and how this could be the best fit for different aspects of cancer care-related challenges.[29]

While this report provided a good overview of BCT-ML fusion in the healthcare field, it does not capture a complete picture, as there is an increasing number of promising developments in this cutting-edge area. Future research on this area of technology integration should consider the addition of more BCT technical details. Although this report provided an example of integrating of ML and BCT in cancer survivorship care, future research should explore further integration of other AI solutions with BCT in various real-world applications as other AI domains and BCT become increasingly powerful and robust,[30] thus moving these technology fusions forward in this area.[31]


  Conclusions Top


ML and BCT are two data-driven technologies, and there is rapidly growing interest in integrating them for clinical data management and analysis in healthcare. This report provided relevant literature under this topic in the health domain and describes the implications for cancer care. Guided by the findings of the first stage, the second stage of this report gave an example of how to apply these two technologies in cancer survivorship care. Thus, this brief report indicated that both technologies can be integrated feasibly and effectively. Future research should explore wider and deeper integration of these most notable technologies in cancer care.

Acknowledgments

The authors sincerely thank Professor Winnie So's valuable comments and advice for this brief report.

Financial support and sponsorship

This study was funded by the National Natural Science Foundation of China (Grant No. 72004039).

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021;71:209-49.  Back to cited text no. 1
    
2.
Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Global Cancer Observatory: Cancer Today. Lyon: International Agency for Research on Cancer; 2020. Available from: https://gco.iarc.fr/today. [Last accessed on 2021 Feb 21].  Back to cited text no. 2
    
3.
Cancer Research UK. Cancer Survival Statistics for All Cancers Combined. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/survival/all-cancers-combined. [Last accessed on 2021 May 02].  Back to cited text no. 3
    
4.
Tran N, Dunn N, Moore J, Guan T, Philpot S. Cancer in Queensland: Statistical Overview 1982-2021. Available from: https://cancerallianceqld.health.qld.gov.au/media/1441/cancerinqueenslandannualupdate2014.pdf. [Last accessed on 2021 May 02].  Back to cited text no. 4
    
5.
Dlamini Z, Francies FZ, Hull R, Marima R. Artificial intelligence (AI) and big data in cancer and precision oncology. Comput Struct Biotechnol J 2020;18:2300-11.  Back to cited text no. 5
    
6.
Hamet P, Tremblay J. Artificial intelligence in medicine. Metabolism 2017;69S:S36-40.  Back to cited text no. 6
    
7.
Hemphill GM. A Review of Current Machine Learning Methods Used for Cancer Recurrence Modeling and Prediction. United States: Los Alamos National Laboratory; 2016.  Back to cited text no. 7
    
8.
Kourou K, Exarchos TP, Exarchos KP, Karamouzis MV, Fotiadis DI. Machine learning applications in cancer prognosis and prediction. Comput Struct Biotechnol J 2015;13:8-17.  Back to cited text no. 8
    
9.
van IJzendoorn DG, Szuhai K, Briaire-de Bruijn IH, Kostine M, Kuijjer ML, Bovée JV. Machine learning analysis of gene expression data reveals novel diagnostic and prognostic biomarkers and identifies therapeutic targets for soft tissue sarcomas. PLoS Comput Biol 2019;15:e1006826.  Back to cited text no. 9
    
10.
Zhu W, Xie L, Han J, Guo X. The application of deep learning in cancer prognosis prediction. Cancers (Basel) 2020;12:E603.  Back to cited text no. 10
    
11.
Dubovitskaya A, Novotny P, Xu Z, Wang F. Applications of blockchain technology for data-sharing in oncology: Results from a systematic literature review. Oncology 2020;98:403-11.  Back to cited text no. 11
    
12.
Rajkomar A, Oren E, Chen K, Dai AM, Hajaj N, Hardt M, et al. Scalable and accurate deep learning with electronic health records. NPJ Digit Med 2018;1:18.  Back to cited text no. 12
    
13.
Kuo TT, Kim HE, Ohno-Machado L. Blockchain distributed ledger technologies for biomedical and health care applications. J Am Med Inform Assoc 2017;24:1211-20.  Back to cited text no. 13
    
14.
Agbo CC, Mahmoud QH, Eklund JM. Blockchain technology in healthcare: A systematic review. Healthcare (Basel) 2019;7:E56.  Back to cited text no. 14
    
15.
Mamoshina P, Ojomoko L, Yanovich Y, Ostrovski A, Botezatu A, Prikhodko P, et al. Converging blockchain and next-generation artificial intelligence technologies to decentralize and accelerate biomedical research and healthcare. Oncotarget 2018;9:5665-90.  Back to cited text no. 15
    
16.
Glicksberg BS, Burns S, Currie R, Griffin A, Wang ZJ, Haussler D, et al. Blockchain-authenticated sharing of genomic and clinical outcomes data of patients with cancer: A prospective cohort study. J Med Internet Res 2020;22:e16810.  Back to cited text no. 16
    
17.
Mackey TK, Kuo TT, Gummadi B, Clauson KA, Church G, Grishin D, et al. 'Fit-for-purpose?'-challenges and opportunities for applications of blockchain technology in the future of healthcare. BMC Med 2019;17:68.  Back to cited text no. 17
    
18.
Nicora G, Vitali F, Dagliati A, Geifman N, Bellazzi R. Integrated multi-omics analyses in oncology: A review of machine learning methods and tools. Front Oncol 2020;10:1030.  Back to cited text no. 18
    
19.
Chattu VK, Nanda A, Chattu SK, Kadri SM, Knight AW. The emerging role of blockchain technology applications in routine disease surveillance systems to strengthen global health security. Big Data Cognit Comput 2019;3:25.  Back to cited text no. 19
    
20.
Juneja A, Marefat M. Leveraging Blockchain for Retraining Deep Learning Architecture in Patient-Specific Arrhythmia Classification. In 2018 IEEE EMBS International Conference on Biomedical Health Informatics (BHI); 2018. p. 393-7.  Back to cited text no. 20
    
21.
Hathaliya J, Sharma P, Tanwar SS, Gupta R. Blockchain-Based Remote Patient Monitoring in Healthcare 4.0, 2019 IEEE 9th International Conference on Advanced Computing (IACC), Tiruchirappalli, India; 2019. p. 87-91. [doi: 10.1109/IACC48062.2019.8971593].  Back to cited text no. 21
    
22.
Kuo TT, Ohno-Machado L. ModelChain: Decentralized Privacy-Preserving Healthcare Predictive Modeling Framework on Private Blockchain Networks; arXiv: 1802.01746. https://arxiv.org/abs/1802.01746. [Last accessed on 2021 May 2].  Back to cited text no. 22
    
23.
Shae Z, Tsai J. Transform Blockchain into Distributed Parallel Computing Architecture for Precision Medicine, 2018 IEEE 38th International Conference on Distributed Computing Systems (ICDCS), Vienna, Austria; 2018. p. 1290-9. [doi: 10.1109/ICDCS.2018.00129].  Back to cited text no. 23
    
24.
Grosan C, Abraham A. Rule-based expert systems. In: Intelligent Systems. Intelligent Systems Reference Library. Vol. 17. Berlin, Heidelberg: Springer; 2011.  Back to cited text no. 24
    
25.
Siyal AA, Junejo AZ, Zawish M, Ahmed K, Khalil A, Soursou G. Applications of blockchain technology in medicine and healthcare: Challenges and future perspectives. Cryptography 2019;3:3.  Back to cited text no. 25
    
26.
Medicalchain: A Smart Medical Ecosystem. Available from: https://medicalchain.com/en/. [Last accessed on 2021 May 02].  Back to cited text no. 26
    
27.
Ali O, Jaradat A, Kulakli A, Abuhalimeh A. A comparative study: Blockchain technology utilization benefits, challenges and functionalities. IEEE Access 2021;9:12730-49.  Back to cited text no. 27
    
28.
Agbo CC, Mahmoud QH. Blockchain in healthcare: Opportunities, challenges, and possible solutions. Int J Healthc Inf Syst Inform 2020;15:82-97.  Back to cited text no. 28
    
29.
Khatoon A. A blockchain-based smart contract system for healthcare management. Electronics 2020;9:94.  Back to cited text no. 29
    
30.
Khezr S, Moniruzzaman M, Yassine A, Benlamri R. Blockchain technology in healthcare: A comprehensive review and directions for future research. Appl Sci 2019;9:1736.  Back to cited text no. 30
    
31.
Boulos MN, Wilson JT, Clauson KA. Geospatial blockchain: Promises, challenges, and scenarios in health and healthcare. Int J Health Geogr 2018;17:25.  Back to cited text no. 31
    


    Figures

  [Figure 1]
 
 
    Tables

  [Table 1]



 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
Abstract
Introduction
Methods
Results
Discussion
Conclusions
References
Article Figures
Article Tables

 Article Access Statistics
    Viewed276    
    Printed4    
    Emailed0    
    PDF Downloaded28    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]